Lukas Kraehenbuehl

14PUBLICATIONS
83CO-AUTHORS
AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of diseaseCellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 26, 2026
Incidence, severity and potential pathomechanism of immune-related pruritus in melanoma patients undergoing immune checkpoint inhibitor therapy.

Andrea Roggo, Nikolina Ivanovic, Patrick Turko

|Jun 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.

Lukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko

|Oct 26, 2024
Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process.

Z Apalla, A Freites-Martinez, K Grafanaki

|Apr 23, 2024
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.

Mario E Lacouture, Elena Goleva, Neil Shah

|Mar 13, 2024
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.

Ramon Staeger, Julia M Martínez-Gómez, Patrick Turko

|Nov 21, 2023
Validation and Responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in Breast Cancer Patients.

L Kraehenbuehl, D Kang, A S Bang

Pageof 3

Frequent Collaborators

4 joint publications

Mario E Lacouture

3 joint publications

Zoe Apalla

3 joint publications

Azael Freites-Martinez

3 joint publications

Vincent Sibaud